Kim Kelderman - Aug 15, 2023 Form 4/A - Amendment Insider Report for BIO-TECHNE Corp (TECH)

Role
Pres. Diagnostics & Genom
Signature
/s/ Andrew Nick, Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
Stock symbol
TECH
Transactions as of
Aug 15, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
12/14/2023, 06:13 PM
Date Of Original Report
Aug 17, 2023
Previous filing
Aug 8, 2023
Next filing
Aug 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Award $0 +8.87K $0.00 8.87K Aug 15, 2023 Common Stock 8.87K Direct F1, F2
transaction TECH Stock Options (Right to Buy) Award $0 +23.9K $0.00 23.9K Aug 15, 2023 Common Stock 23.9K $84.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2 Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Remarks:

This amendment is being filed to correct the number of restricted stock units and performance options being granted.